(Erstwhile UTI Pharma & Healthcare Fund) Table of Contents The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis UTI Healthcare Fund - G
Scheme Objective
CAGR
return of 15% since its launch. Ranked 40 in Sectoral
category. Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% . NAV as on 25 Jul 24 ₹253.383 ↑ 2.02 (0.81 %) Net Assets (AUM) as on 30 Jun 2024 ₹986 Cr. Launch Date 28 Jun 1999 Category Equity - Sectoral Rating ☆ Type Open Ended Fund Risk High AMC UTI Asset Management Company Ltd Alpha Ratio 1.28 Expense Ratio 2.49 % Sharpe Ratio 2.126 Information Ratio -0.42 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-1 Years (1%),1 Years and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 25 Jul 24 Duration Returns 1 Month 8.1% 3 Month 13.3% 6 Month 19.5% 1 Year 46.9% 3 Year 14.2% 5 Year 26.2% 10 Year 15 Year Since launch 15% Historical Annual Returns
Year Returns 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Growth of 10k Over Years
Date Value 30 Jun 19 ₹10,000 30 Jun 20 ₹13,193 30 Jun 21 ₹20,810 30 Jun 22 ₹17,643 30 Jun 23 ₹20,822 30 Jun 24 ₹29,683 Asset Allocation
Asset Class Value Cash 1.38% Equity 98.5% Debt 0.13% Sector Allocation
Sector Value Health Care 95.52% Financial Services 1.63% Basic Materials 1.35% Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMADrug Manufacturers - Specialty & Generic 11% ₹112 Cr 735,274
↓ -24,726 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLADrug Manufacturers - General 7% ₹65 Cr 440,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDYDrug Manufacturers - Specialty & Generic 6% ₹56 Cr 87,100
↑ 8,917 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARMDrug Manufacturers - Specialty & Generic 5% ₹52 Cr 227,802
↓ -11,328 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSPMedical Care Facilities 4% ₹40 Cr 64,796
↓ -3,212 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHLDrug Manufacturers - Specialty & Generic 4% ₹37 Cr 74,000
↑ 8,451 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Jun 21 | 543308Medical Care Facilities 4% ₹35 Cr 170,000
↑ 8,416 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERISDrug Manufacturers - Specialty & Generic 3% ₹31 Cr 306,918
↓ -39,236 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLANDDrug Manufacturers - General 3% ₹31 Cr 170,000 Suven Pharmaceuticals Ltd (Healthcare)
Equity, Since 28 Feb 21 | SUVENPHARDrug Manufacturers - Specialty & Generic 3% ₹31 Cr 385,616
↓ -14,384
Talk to our investment specialistFund Managers
Name Since Tenure Kamal Gada 2 May 22 2.17 Yr. Custodians
Company Address Bank of Nova Scotia 12/13, Maker Chamber VI,220, Nariman Point Citibank N.A. India Trent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East), Stock Holding Corporation of India Mittal Court, ‘B’ Wing,,Nariman Point Registrar & Transfer Agent
KFin Technologies Ltd Address KFin Technologies Pvt. Ltd,,1D/D Extension 2, Valmiki Chowk,,Gandhi Nagar, FAX 91-40-23311968 Email mailmanager@karvy.com Administrator Companies
Company Address UTI Mutual Fund UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E) Auditors
Company Address Haribhakti & Co. Chartered Accountants 42, Free Press House,4th Floor,,215, Nariman Point, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year UTI Healthcare Fund
Growth ₹253.383
↑ 2.02 19.55 % 46.9 % 14.22 % 26.18 % UTI Healthcare Fund
Normal Dividend, Payout ₹195.83
↑ 1.56 19.55 % 46.9 % 14.22 % 26.18 % UTI Healthcare Fund
Normal Dividend, Reinvestment ₹195.83
↑ 1.56 19.55 % 46.9 % 14.22 % 26.18 % Data as on 25 Jul 24